A practical, research-aligned guide to tapering, managing hunger rebound, and maintaining control after GLP-1 therapy.
Instant digital download. One-time purchase.

Stopping a GLP-1 is a transition, whether you are planning it, tapering, or already off.
Appetite, food noise, and eating effort change during and after treatment.They change again when the medication wears off.This guide documents what typically happens and how people manage it.

Understand what typically changes when treatment ends, and how timing, exercise, and nutrition choices influence your transition.

See what usually happens at each dose step, how long transitions take, and which adjustments help stabilize hunger and weight.

Learn the typical off-medication timeline, what stabilizes and when, and which factors influence maintenance or early regain.
Free Overview
10 things to know before stopping a GLP-1
A short PDF summarizing common changes, timing patterns, and early considerations during the transition.
Receive the PDF by email. →
Unsubscribe anytime.
A practical, research-aligned guide
to stopping GLP-1 medications
without losing progress.
PDF guide • Immediate access
One-time purchase. Includes the full guide and all future updates.
Not medical advice. Designed to help you understand your options and have better conversations with your doctor.
The Transition
What typically changes as doses decrease or stop
Hunger rebound explained (timing + intensity)
Physical, emotional, and behavioral shifts
Managing the Change
Nutrition and exercise approaches
Practical adjustments during taper/off
Strategies that help vs backfire
Medication Context
Tapering patterns for major GLP-1s
Transition medications and doctor discussion points
Special Situations
Diabetes
Long-term high-dose users
Older adults
Pregnancy considerations
Large weight loss
Longer-Term Maintenance
What real-world data shows
Stabilization patterns
Personal exit-plan worksheet
Not medical advice. Designed to help you understand your options and have better conversations with your doctor.
There’s still no official, universally accepted protocol for stopping GLP-1 medications. Doctors are piecing together guidance from emerging research, pharmacology, and real-world experience.This table summarizes the patterns that are showing up consistently across clinics, early studies, and large patient communities. It’s not a prescription — it’s a map of the current landscape.
| Drug | Common Taper Patterns | Typical Timeline | Key Challenge | Maintenance Challenge Level |
|---|---|---|---|---|
| Wegovy pill (oral semaglutide) | Step down through dose tiers | 3–5 months | New drug, limited real-world data | Unknown |
| Ozempic (semaglutide) | Often stepped down in 0.25mg increments over several months | 3–6 months | Hunger rebound at lower doses | Moderate–Hard |
| Wegovy injection (semaglutide) | Often tapered by reversing the original titration schedule | 4–6 months | Appetite surge after stopping | Hard |
| Mounjaro (tirzepatide) | Step down by 2.5mg every 4–8 weeks | 3–6 months | Less data available | Moderate |
| Zepbound (tirzepatide) | Similar patterns to Mounjaro | 3–6 months | Newer drug, limited protocols | Moderate |
| Compounded semaglutide | Varies widely by provider | Varies | Inconsistent dosing makes tapering harder | Moderate–Hard |
The drug matters — but your process matters more.
Gradual tapering, habit-building, and the first 8–20 weeks after stopping have a far bigger impact on long-term maintenance than which GLP-1 you were on.This is not medical advice. It reflects emerging practices as of 2026 and will evolve as more research arrives.
What people typically want to know before buying.
Are you a doctor or medical provider?
No. SoftExits does not provide medical advice, prescriptions, or treatment plans. We’re an information resource — designed to help you understand what’s known, what’s uncertain, and how to have more productive conversations with your doctor.
Who is this for?
If you’re on a GLP-1 medication — Ozempic, Wegovy (injection or pill), Mounjaro, Zepbound, or compounded semaglutide — and you’re thinking about stopping, tapering now, or already off and trying to maintain, this guide is for you.
Most people on GLP-1s eventually ask: What happens when I stop?
This guide exists for that moment.
What's inside the guide?
A structured, research-aligned overview of what’s emerging around GLP-1 discontinuation, including:
- Common tapering patterns
- What typically changes week by week
- Hunger rebound: causes, timing, and management
- Maintenance nutrition and exercise strategies
- Honest data on weight regain — without fear-mongering or false promises
No fluff. No miracle claims.
Is this just information I could find on Reddit?
Some of it exists there — scattered across hundreds of threads.
SoftExits pulls together clinical guidance, emerging research, and large-scale real-world experience into a single, coherent resource you can actually use.
Will this tell me exactly how to taper?
No — and that’s intentional.
We outline commonly used tapering approaches and what’s emerging in practice, but your taper should be supervised by your prescribing doctor. The guide helps you understand your options and ask better, more specific questions.
Can this replace my doctor?
No. Think of this as the step before your appointment.
Instead of going in blind or overwhelmed, you show up informed — which usually leads to better decisions and better outcomes.
What if I gain the weight back anyway?
Some regain is biologically likely — that’s the honest truth. But how you stop matters far more than most people realize.People who taper gradually, build habits while still on medication, and have a plan for the first 8–20 weeks after stopping maintain their loss at far higher rates than those who stop cold turkey.This guide won’t promise perfection. It will show you the evidence-based strategies that put you in the better-outcome group — and help you avoid the patterns that lead to fast rebound.
What if the information changes?
You’ll always have the latest version.
As new research emerges and clinical practices evolve, the guide will be updated — and you’ll automatically get access to every update.
What if I've already stopped?
The guide covers that too.
There’s a full section on post-GLP-1 maintenance: managing hunger, nutrition, activity, and mindset after the medication is fully out of your system.
Is there a refund policy?
Because the guide is delivered immediately as a digital product, all sales are final. That said, if you feel it didn’t deliver value, email us and we’ll do our best to make it right.
Last updated: January 2026
What We Collect
We collect only the information necessary to operate SoftExits and deliver the guide:
Email address (if you purchase the guide or opt in to updates)
Payment information (processed securely by Stripe — we do not store card details)
Basic, privacy-friendly analytics (page views and general usage, no cookies or cross-site tracking)
We do not collect health data, medical records, or sensitive personal information.
How We Use Your Information
We use your information only to:
Deliver access to the Soft Exit Guide
Send transactional emails related to your purchase
Send occasional updates if you’ve explicitly opted in
Improve the guide using anonymized, aggregated insights
We do not use your information for advertising or behavioral tracking.
Who Has Access to Your Data
Your information is accessible only to SoftExits and trusted service providers required to operate the site, including:
Stripe (payment processing)
Email delivery services (for sending the guide and updates)
Analytics providers (privacy-focused, non-identifying)
We do not sell, rent, or share your personal information with third parties.
Your Rights
You may:
Unsubscribe from non-transactional emails at any time
Request deletion of your personal data by emailing [email protected]
Request access to or correction of your information
We retain transaction records as required by law, but will remove other personal data upon request.
What SoftExits Provides
SoftExits provides a paid digital guide offering:
Research-informed information about discontinuing GLP-1 medications
Summaries of emerging clinical practices and real-world experiences
General guidance intended to help readers understand options and prepare for discussions with healthcare providers
The guide is informational only and is updated periodically as new research emerges.
What SoftExits Does Not Provide
SoftExits does not provide:
Medical advice, diagnosis, or treatment
Prescriptions or medication management
Personalized health recommendations
Guarantees of weight loss, weight maintenance, or specific outcomes
Nothing in the guide should be interpreted as a substitute for professional medical care.
Your Responsibility
You are responsible for all decisions you make regarding your health.Any changes to medication, dosing, or treatment should be discussed with and supervised by your prescribing healthcare provider. SoftExits exists to support informed decision-making — not replace medical judgment.
Refunds
Because the guide is delivered immediately as a digital product, all sales are final.
If you believe the guide did not deliver value, you may contact [email protected], and we will review your request in good faith.
Limitations of Liability
SoftExits provides information to support your understanding, not to guarantee outcomes. To the fullest extent permitted by law, SoftExits is not liable for:
Decisions you make based on the guide
Health outcomes, weight changes, or side effects
Accuracy of third-party sources referenced
Any indirect or consequential damages
Our total liability is limited to the amount you paid for the guide.Updates to These Terms
We may update this Privacy Policy and Terms of Use from time to time. Continued use of SoftExits after changes are posted constitutes acceptance of the updated terms.Contact
Questions about privacy or terms?
Email [email protected]
We’ll send your secure download instructions shortly.
Your checklist should arrive in the next 2 minutes.If you want the full implementation plan—taper schedules, hunger management protocols, transition medications, and what to expect week by week—the guide is here:
One-time purchase. Updated as research evolves.Not medical advice. Designed to help you understand your options.
You'll get occasional updates when something significant changes in the GLP-1 discontinuation space—new research, protocol updates, insurance/access changes.